Bi F - Search Results

1

CaMKII suppresses proteotoxicity by phosphorylating BAG3 in response to proteasomal dysfunction.

Zhang C, Xu H, Tang Q, Duan Y, Xia H, Huang H, Ye D, Bi F. Zhang C, et al. Among authors: bi f. EMBO Rep. 2024 Oct;25(10):4488-4514. doi: 10.1038/s44319-024-00248-w. Epub 2024 Sep 11. EMBO Rep. 2024. PMID: 39261742 Free PMC article.

2

Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.

Yu H, Xia H, Tang Q, Xu H, Wei G, Chen Y, Dai X, Gong Q, Bi F. Yu H, et al. Among authors: bi f. Sci Rep. 2017 Jan 19;7:40802. doi: 10.1038/srep40802. Sci Rep. 2017. PMID: 28102288 Free PMC article.

3

Long noncoding RNA‑ATB promotes cell proliferation, migration and invasion in gastric cancer.

Chen Y, Wei G, Xia H, Tang Q, Bi F. Chen Y, et al. Among authors: bi f. Mol Med Rep. 2018 Jan;17(1):1940-1946. doi: 10.3892/mmr.2017.8077. Epub 2017 Nov 15. Mol Med Rep. 2018. PMID: 29257203

4

Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib.

Liu BS, Dai XY, Xia HW, Xu HJ, Tang QL, Gong QY, Nie YZ, Bi F. Liu BS, et al. Among authors: bi f. Mol Med Rep. 2018 Oct;18(4):4023-4029. doi: 10.3892/mmr.2018.9371. Epub 2018 Aug 9. Mol Med Rep. 2018. PMID: 30106149

5

Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.

Liu BS, Xia HW, Zhou S, Liu Q, Tang QL, Bi NX, Zhou JT, Gong QY, Nie YZ, Bi F. Liu BS, et al. Among authors: bi f, bi nx. Oncol Rep. 2018 Oct;40(4):2171-2182. doi: 10.3892/or.2018.6630. Epub 2018 Aug 7. Oncol Rep. 2018. PMID: 30106444

6

Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway.

Zhou S, Xu H, Tang Q, Xia H, Bi F. Zhou S, et al. Among authors: bi f. Mol Cancer Ther. 2020 Jan;19(1):135-146. doi: 10.1158/1535-7163.MCT-19-0413. Epub 2019 Sep 25. Mol Cancer Ther. 2020. PMID: 31554653

7

Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer.

Xu H, Xia H, Zhou S, Tang Q, Bi F. Xu H, et al. Among authors: bi f. Cell Death Discov. 2021 Feb 26;7(1):38. doi: 10.1038/s41420-021-00421-3. Cell Death Discov. 2021. PMID: 33637695 Free PMC article.

8

The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells.

Zhang H, Xu H, Tang Q, Bi F. Zhang H, et al. Among authors: bi f. Anticancer Drugs. 2021 Sep 1;32(8):793-801. doi: 10.1097/CAD.0000000000001067. Anticancer Drugs. 2021. PMID: 33675613

9

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.

Zhu G, Xia H, Tang Q, Bi F. Zhu G, et al. Among authors: bi f. Cancer Cell Int. 2021 Mar 12;21(1):166. doi: 10.1186/s12935-021-01864-5. Cancer Cell Int. 2021. PMID: 33712026 Free PMC article.

10

Casp8 acts through A20 to inhibit PD-L1 expression: The mechanism and its implication in immunotherapy.

Zou J, Xia H, Zhang C, Xu H, Tang Q, Zhu G, Li J, Bi F. Zou J, et al. Among authors: bi f. Cancer Sci. 2021 Jul;112(7):2664-2678. doi: 10.1111/cas.14932. Epub 2021 May 20. Cancer Sci. 2021. PMID: 33934451 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

693 results

Search Page

Filters